Back to BlackRock, Inc. BlackRock, Inc.

NGNENGNE
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in NEUROGENE INC

BlackRock, Inc. holds 1.1M shares of NGNE (NEUROGENE INC), worth $33.3M as of 2026-Q2. The position was increased (+5.3% shares). NGNE represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$33.3M

Current Shares

1.1M

Total Value Change

-$1.4M

Total Shares Change

-458,174

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+5.3%
$33.3M0.0%$31.45
30
2026-Q1
Increased
1M
+6.3%
$20.3M0.0%$21.99
30
2025-Q4
Decreased
945,583
-0.6%
$19.5M0.0%$22.11
0
2025-Q3
Decreased
951,100
-2.7%
$16.5M0.0%$17.71
0
2025-Q2
Decreased
977,682
-30.1%
$14.6M0.0%$16.16
0
2025-Q1
Decreased
1.4M
-7.7%
$16.4M0.0%$14.52
0
2024-Q4
New
1.5M
-
$34.7M0.0%$22.28
40

Other major holders of NGNE: BlackRock Finance, Inc., RTW INVESTMENTS, LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used